Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d test

LUND, SWEDEN - The California Department of Public Health has granted Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), a Clinical and Public Health Laboratory license, allowing physicians in California to order the IMMray PanCan-d test for their patients.

 

"People at risk for pancreatic cancer need better tools for early detection. We are thrilled that this approval enables us to make IMMray PanCan-d available to clinicians in California who care for those at risk." says Jeff Borcherding, Chief Executive Officer of Immunovia, Inc.

 

 

For more information, please contact:
Philipp Mathieu
CEO and President
Email: [e-mail]
 

Karin Almqvist Liwendahl
Chief Financial Officer
Email: [e-mail]

 

The information was submitted for publication on August 10, 2022, at 09:55 am CET.

 

 

About Immunovia
Immunovia AB is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer.

Our first product, IMMray(TM) PanCan-d is the only blood test currently available specifically for the early detection of pancreatic cancer. The test has unmatched clinical performance. Commercialization of IMMray(TM) PanCan-d started in August 2021 in the USA and IMMray(TM) PanCan-d is offered as a laboratory developed test (LDT) exclusively through Immunovia, Inc. For more information see: www.immunoviainc.com.

Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups globally to make this test available to all high-risk pancreatic cancer groups. 

The USA, the first market in which IMMray(TM) PanCan-d is commercially available, is the world's largest market for the detection of pancreatic cancer with an estimated value of more than USD 4 billion annually.

Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit www.immunovia.com. 

###

https://news.cision.com/immunovia-ab/r/immunovia--inc--issued-clinical-and-public-health-laboratory-license-from-california-dept-of-public-,c3612734

https://mb.cision.com/Main/13121/3612734/1613663.pdf

(c) 2022 Cision. All rights reserved., source Press Releases - English